サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：オキシコドン塩酸塩の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測
市場調査レポート
商品コード
1346810

オキシコドン塩酸塩の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測

Global Oxycodone Hydrochloride Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 231 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
オキシコドン塩酸塩の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測
出版日: 2023年08月01日
発行: Value Market Research
ページ情報: 英文 231 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

オキシコドン塩酸塩市場の世界需要は、2022年の4億623万米ドルから2030年には6億1,265万米ドル近くの市場規模に達すると推定され、調査期間2023年～2030年のCAGRは5.27%です。

オキシコドン塩酸塩は強力なオピオイド鎮痛薬で、中等度から重度の疼痛管理に使用されます。オピオイド作動薬として知られる薬効分類に属します。さまざまな期間にわたって鎮痛効果を発揮するため、即時放出型や徐放型など、さまざまな製剤が販売されています。

市場力学：

オキシコドン塩酸塩市場の成長は、いくつかの要因に影響されています。主に、医療処置後、手術後、外傷、怪我、がん関連の疼痛など、中等度から重度の疼痛の場合、効果的な疼痛管理の必要性が高まっていることが背景にあります。世界人口の高齢化と慢性疼痛疾患の蔓延が需要の増加に寄与しています。医療従事者の処方習慣、ヘルスケア・インフラ、疼痛管理の選択肢に関する意識は、その利用率に影響を与えています。規制の枠組み、製薬業界の力学、オピオイド処方に関するガイドラインも一役買っています。市場の進化は、疼痛緩和のニーズと関連するリスクや課題とのバランスを取るための継続的な取り組みという文脈で理解されなければならないです。オキシコドン塩酸塩市場の現状を理解するには、信頼できる医療情報源を通じて常に情報を得ることが不可欠です。

この調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールはオキシコドン塩酸塩の世界市場における各セグメントを包括的に評価することもできます。オキシコドン塩酸塩産業の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析：

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東＆アフリカにおけるオキシコドン塩酸塩市場の現在および将来の需要を強調する地域展望をカバーします。さらに、本レポートは、すべての主要地域における個々の用途セグメントの需要、推定・予測に焦点を当てています。

特注のご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 オキシコドン塩酸塩-産業分析

  • イントロダクション-市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 オキシコドン塩酸塩の世界市場分析：タイプ別

  • タイプ別概要
  • 実績データと予測データ
  • タイプ別分析
  • 放出制御型
  • 即時放出型

第6章 オキシコドン塩酸塩の世界市場分析：投与経路別

  • 投与経路別概要
  • 実績データと予測データ
  • 投与経路別分析
  • 経口
  • 非経口

第7章 オキシコドン塩酸塩の世界市場分析：流通チャネル別

  • 流通チャネル別概要
  • 実績データと予測データ
  • 流通チャネル別分析
  • 病院
  • 小売薬局

第8章 オキシコドン塩酸塩の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第9章 オキシコドン塩酸塩企業の競合情勢

  • オキシコドン塩酸塩市場の競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第10章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Eli Lilly and Co.
  • Gilead Sciences Inc.
  • Manus Aktteva Biopharma LLP
  • Arevipharma
  • Saneca Pharma
  • Cipla Ltd
  • Noramco
  • Macfarian Smith
  • Teva Pharmaceutical Industries Ltd
  • Taj Pharma
  • Chattem Chemicals Inc.
  • Mayne Pharma Group Limited
  • Dr. Reddy's Laboratories Ltd
  • Siegfried
  • Rhodes Pharmaceuticals
  • Mallinckrodt Plc
  • Johnson & Johnson
  • Bristol-Myers Squibb Company
  • Sun Pharmaceutical Industries Ltd
  • Lupin Ltd
  • Sanofi Sais
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Controlled-Release Market Sales by Geography (USD MN)
  • Immediate-Release Market Sales by Geography (USD MN)
  • Analysis Market by Route of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Parenteral Market Sales by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Global Oxycodone Hydrochloride Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Oxycodone Hydrochloride Report
  • Market Research Process
  • Market Research Methodology
  • Global Oxycodone Hydrochloride Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Route of Administration
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Controlled-Release Market Sales by Geography (USD MN)
  • Immediate-Release Market Sales by Geography (USD MN)
  • Global Market Analysis by Route of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Parenteral Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112112072

The global demand for Oxycodone Hydrochloride Market is presumed to reach the market size of nearly USD 612.65 MN by 2030 from USD 406.23 MN in 2022 with a CAGR of 5.27% under the study period 2023 - 2030.

Oxycodone hydrochloride is a powerful opioid analgesic medication used to manage moderate to severe pain. It belongs to the class of medications known as opioid agonists. It is available in various formulations, including immediate-release and extended-release versions, to provide pain relief over different time periods.

MARKET DYNAMICS:

The growth of the oxycodone hydrochloride market is influenced by several factors. It is primarily driven by the increasing need for effective pain management in cases of moderate to severe pain, such as after medical procedures, surgeries, trauma, injury, and cancer-related pain. The aging global population and the prevalence of chronic pain conditions contribute to the rising demand. Medical professionals' prescription practices, healthcare infrastructure, and awareness about pain management options impact its utilization. Regulatory frameworks, pharmaceutical industry dynamics, and guidelines for opioid prescription also play a role. The market's evolution must be understood in the context of the ongoing efforts to balance pain relief needs with the associated risks and challenges. Staying informed through reliable medical sources is essential for understanding the current state of the oxycodone hydrochloride market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of oxycodone hydrochloride. The growth and trends of oxycodone hydrochloride industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the oxycodone hydrochloride market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Controlled-Release
  • Immediate-Release

By Route Of Administration

  • Oral
  • Parenteral

By Distribution Channel

  • Hospitals
  • Retail Pharmacies

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Oxycodone Hydrochloride market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Oxycodone Hydrochloride market include Eli Lilly and Co., Gilead Sciences Inc., Manus Aktteva Biopharma LLP, Arevipharma, Saneca Pharma, Cipla Ltd, Noramco, Macfarian Smith, Teva Pharmaceutical Industries Ltd, Taj Pharma, Chattem Chemicals Inc., Mayne Pharma Group Limited, Dr. Reddy's Laboratories Ltd, Siegfried, Rhodes Pharmaceuticals, Mallinckrodt Plc, Johnson & Johnson, Bristol-Myers Squibb Company, Sun Pharmaceutical Industries Ltd, Lupin Ltd, and Sanofi Sais. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . OXYCODONE HYDROCHLORIDE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Route of Administration
    • 3.7.3 Market Attractiveness Analysis By Distribution Channel
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL OXYCODONE HYDROCHLORIDE MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 Controlled-Release Historic and Forecast Sales by Regions
  • 5.5 Immediate-Release Historic and Forecast Sales by Regions

6 . GLOBAL OXYCODONE HYDROCHLORIDE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 6.1 Overview by Route of Administration
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Route of Administration
  • 6.4 Oral Historic and Forecast Sales by Regions
  • 6.5 Parenteral Historic and Forecast Sales by Regions

7 . GLOBAL OXYCODONE HYDROCHLORIDE MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 7.1 Overview by Distribution Channel
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Distribution Channel
  • 7.4 Hospitals Historic and Forecast Sales by Regions
  • 7.5 Retail Pharmacies Historic and Forecast Sales by Regions

8 . GLOBAL OXYCODONE HYDROCHLORIDE MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. South East Asia Sales Analysis
    • 8.5.10. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE OXYCODONE HYDROCHLORIDE COMPANIES

  • 9.1. Oxycodone Hydrochloride Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF OXYCODONE HYDROCHLORIDE INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Eli Lilly and Co.
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Gilead Sciences Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Manus Aktteva Biopharma LLP
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Arevipharma
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Saneca Pharma
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Cipla Ltd
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Noramco
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Macfarian Smith
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Teva Pharmaceutical Industries Ltd
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Taj Pharma
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments
  • 10.13. Chattem Chemicals Inc.
    • 10.13.1. Company Overview
    • 10.13.2. Company Revenue
    • 10.13.3. Products
    • 10.13.4. Recent Developments
  • 10.14. Mayne Pharma Group Limited
    • 10.14.1. Company Overview
    • 10.14.2. Company Revenue
    • 10.14.3. Products
    • 10.14.4. Recent Developments
  • 10.15. Dr. Reddy's Laboratories Ltd
    • 10.15.1. Company Overview
    • 10.15.2. Company Revenue
    • 10.15.3. Products
    • 10.15.4. Recent Developments
  • 10.16. Siegfried
    • 10.16.1. Company Overview
    • 10.16.2. Company Revenue
    • 10.16.3. Products
    • 10.16.4. Recent Developments
  • 10.17. Rhodes Pharmaceuticals
    • 10.17.1. Company Overview
    • 10.17.2. Company Revenue
    • 10.17.3. Products
    • 10.17.4. Recent Developments
  • 10.18. Mallinckrodt Plc
    • 10.18.1. Company Overview
    • 10.18.2. Company Revenue
    • 10.18.3. Products
    • 10.18.4. Recent Developments
  • 10.19. Johnson & Johnson
    • 10.19.1. Company Overview
    • 10.19.2. Company Revenue
    • 10.19.3. Products
    • 10.19.4. Recent Developments
  • 10.20. Bristol-Myers Squibb Company
    • 10.20.1. Company Overview
    • 10.20.2. Company Revenue
    • 10.20.3. Products
    • 10.20.4. Recent Developments
  • 10.21. Sun Pharmaceutical Industries Ltd
    • 10.21.1. Company Overview
    • 10.21.2. Company Revenue
    • 10.21.3. Products
    • 10.21.4. Recent Developments
  • 10.22. Lupin Ltd
    • 10.22.1. Company Overview
    • 10.22.2. Company Revenue
    • 10.22.3. Products
    • 10.22.4. Recent Developments
  • 10.23. Sanofi Sais
    • 10.23.1. Company Overview
    • 10.23.2. Company Revenue
    • 10.23.3. Products
    • 10.23.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies